| Year | Title | Author(s) |
| 2022 |
Genome-wide screening identifies cell-cycle control as a synthetic lethal pathway with SRSF2P95H mutation
Blood Advances |
Xu, JJ Chalk, AM Nikolic, I Simpson, KJ Smeets, MF Walkley, CR |
| 2022 |
Srsf2(P95H/+) co-operates with loss of TET2 to promote myeloid bias and initiate a chronic myelomonocytic leukemia-like disease in mice
Leukemia |
Xu, JJ Chalk, AM Wall, M Langdon, WY Smeets, MF Walkley, CR |
| 2019 |
Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal
Exp. Hematol. |
Xu, JJ Srneets, MF Tan, SY Wall, M Purton, LE Walkley, CR |
| 2018 |
Srsf2(P95H) initiates myeloid bias and myelodysplastic/myeloproliferative syndrome from hemopoietic stem cells
Blood |
Smeets, MF Tan, SY Xu, JJ Anande, G Unnikrishnan, A Chalk, AM Taylor, SR Pimanda, JE Wall, M Purton, LE Walkley, CR |